Share
𝕏 Facebook LinkedIn

Nociceptin inhibits electric field stimulation-induced cholinergic constrictions in rat airways.

PAPER pubmed Acta pharmacologica Sinica 2000 Animal study Effect: mixed Evidence: Low

Abstract

AIM: To study the effect of nociceptin (orphanin FQ), a newly discovered heptadecapeptide, on cholinergic constrictions in isolated trachea and bronchus of rat. METHODS: The electric field stimulation (EFS) induced a monophasic constriction, which was due to an activation of the cholinergic nerves. RESULTS: Nociceptin 0.001-0.1 mumol/L inhibited cholinergic constriction in a concentration-dependent manner. IC50 (95% of confidence limits) were 0.06 (0.04-0.08) mumol/L and 0.07 (0.05-0.1) mumol/L in tracheae and bronchi respectively. The constrictions inhibited by nociceptin 0.01 mumol/L in traheae and bronchi were (58 +/- 32)% and (60 +/- 26)% respectively compared with the control, in which nociceptin was not applied. After pretreatment with naloxone 0.1 mumol/L, the constrictions were (60 +/- 19)% and (54 +/- 20)% (P > 0.05 vs the above figures). However, the constrictions induced by exogenous acetylcholine were unaffected by nociceptin 0.01 mumol/L. kappa-Opioid receptor agonist, U-50488H (0.01-1 mumol/L) did not affect the EFS-induced cholinergic constrictions in rat airways. CONCLUSION: Nociceptin inhibits EFS-induced cholinergic constriction, which is not affected by naloxone in rat airways.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
mixed
Population
Isolated trachea and bronchus of rat
Sample size
—
Exposure
electric field stimulation (EFS)
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

Electric field stimulation induced a monophasic cholinergic constriction in isolated rat trachea and bronchus. Nociceptin (0.001–0.1 µmol/L) inhibited EFS-induced cholinergic constriction in a concentration-dependent manner; this inhibition was not significantly altered by naloxone pretreatment, and nociceptin did not affect constrictions induced by exogenous acetylcholine. U-50488H did not affect EFS-induced cholinergic constrictions.

Outcomes measured

  • Cholinergic constriction in isolated rat trachea and bronchus (EFS-induced)
  • Response to exogenous acetylcholine
  • Effect of naloxone pretreatment
  • Effect of kappa-opioid receptor agonist U-50488H

Limitations

  • No EFS parameters reported (e.g., frequency, field strength, pulse characteristics).
  • Sample size not reported in abstract.
  • Ex vivo isolated tissue preparation; generalizability to in vivo physiology not established in abstract.
  • Focus is pharmacologic modulation of EFS-evoked responses rather than environmental EMF exposure.
View raw extracted JSON
{
    "study_type": "animal",
    "exposure": {
        "band": null,
        "source": "electric field stimulation (EFS)",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Isolated trachea and bronchus of rat",
    "sample_size": null,
    "outcomes": [
        "Cholinergic constriction in isolated rat trachea and bronchus (EFS-induced)",
        "Response to exogenous acetylcholine",
        "Effect of naloxone pretreatment",
        "Effect of kappa-opioid receptor agonist U-50488H"
    ],
    "main_findings": "Electric field stimulation induced a monophasic cholinergic constriction in isolated rat trachea and bronchus. Nociceptin (0.001–0.1 µmol/L) inhibited EFS-induced cholinergic constriction in a concentration-dependent manner; this inhibition was not significantly altered by naloxone pretreatment, and nociceptin did not affect constrictions induced by exogenous acetylcholine. U-50488H did not affect EFS-induced cholinergic constrictions.",
    "effect_direction": "mixed",
    "limitations": [
        "No EFS parameters reported (e.g., frequency, field strength, pulse characteristics).",
        "Sample size not reported in abstract.",
        "Ex vivo isolated tissue preparation; generalizability to in vivo physiology not established in abstract.",
        "Focus is pharmacologic modulation of EFS-evoked responses rather than environmental EMF exposure."
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "nociceptin",
        "orphanin FQ",
        "electric field stimulation",
        "EFS",
        "cholinergic nerves",
        "trachea",
        "bronchus",
        "rat",
        "airways",
        "acetylcholine",
        "naloxone",
        "U-50488H"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.